IMMUNOMODULATORS CAN BE DISCONTINUED IN PATIENTS ON SCHEDULED INFLIXAMAB TREATMENT

Evidence-Based Gastroenterology ◽

10.1097/ebg.0b013e31818d66f2 ◽

2008 ◽

Vol 9 (4) ◽

pp. 75-77

Author(s):

Darby E. Robinson OʼNeill ◽

Scott D. Lee

Download Full-text